These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 4549507

  • 1. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
    Romaldini JH, Pinchera A, Fenzi GF, Grasso L, Raccis E, Mariotti S, Baschieri L.
    Folia Endocrinol; 1974 Feb; 27(1):110-6. PubMed ID: 4549507
    [No Abstract] [Full Text] [Related]

  • 2. Long-acting thyroid stimulator and related factors.
    Kendall-Taylor P, Dirmikis SM, Munro DS.
    Proc R Soc Med; 1975 Apr; 68(4):252-3. PubMed ID: 1242809
    [No Abstract] [Full Text] [Related]

  • 3. [TSH-receptor-bound antithyroid antibody and the etiology of Basedow's disease].
    Shishiba Y.
    Nihon Rinsho; 1983 Apr; 41(4):801-7. PubMed ID: 6310180
    [No Abstract] [Full Text] [Related]

  • 4. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
    Knight A, Adams DD.
    Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
    [Abstract] [Full Text] [Related]

  • 5. [LATS and other antibodies against the TSH receptor].
    Rodríguez Zapata MM.
    Med Clin (Barc); 1983 Feb; 80(4):177-81. PubMed ID: 6134881
    [No Abstract] [Full Text] [Related]

  • 6. Demonstration of the production of the long acting thyroid stimulator (LATS) by peripheral lymphocytes cultured in vitro.
    Wall JR, Good BF, Forbes IJ, Hetzel BS.
    Clin Exp Immunol; 1973 Aug; 14(4):555-61. PubMed ID: 4201115
    [Abstract] [Full Text] [Related]

  • 7. Radioimmunological studies on the long-acting thyroid stimulator.
    Pinchera A, Rovis L, Grasso L, Liberti P, Martino E, Fenzi GF, Baschieri L.
    Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
    [No Abstract] [Full Text] [Related]

  • 8. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
    Földes J, Takó J, Bános C, Gesztesi E, Varga I.
    Acta Med Acad Sci Hung; 1969 Aug; 26(3):233-43. PubMed ID: 5395883
    [No Abstract] [Full Text] [Related]

  • 9. Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983.
    Munro DS.
    J R Coll Physicians Lond; 1984 Jul; 18(3):155-60. PubMed ID: 6147408
    [No Abstract] [Full Text] [Related]

  • 10. Isoelectric focusing of thyroid-stimulating antibody of Graves' disease.
    Zakarija M, McKenzie JM.
    Endocrinology; 1978 Oct; 103(4):1469-75. PubMed ID: 33803
    [No Abstract] [Full Text] [Related]

  • 11. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies.
    Földes J, Takó J, Bános C, Gesztesi E, Juhász J.
    Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904
    [No Abstract] [Full Text] [Related]

  • 12. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L, Uthgenannt H, Schemmel K, Müller W, Heesen H, Eickenbusch W, Bindeballe W.
    Schweiz Med Wochenschr; 1967 Jul 15; 97(28):898-904. PubMed ID: 5587446
    [No Abstract] [Full Text] [Related]

  • 13. [LATS and other thyroid-stimulating immunoglobulins in the pathogenesis of Basedow's disease].
    Pinchera A, Baschieri L.
    Recenti Prog Med; 1976 Dec 15; 61(6):790-823. PubMed ID: 1037332
    [No Abstract] [Full Text] [Related]

  • 14. The immunologic basis of Graves's disease.
    Volpé R.
    N Engl J Med; 1972 Aug 31; 287(9):463-4. PubMed ID: 5068098
    [No Abstract] [Full Text] [Related]

  • 15. Aetiology of hyperthyroidism. II.
    Hoffenberg R.
    Br Med J; 1974 Aug 24; 3(5929):508-10. PubMed ID: 4369764
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
    Földes J, Krasznai I, Piroska E, Gesztesi E, Takács I.
    Endokrinologie; 1967 Aug 24; 52(1):80-7. PubMed ID: 4171706
    [No Abstract] [Full Text] [Related]

  • 17. Observations on the nature and significance of the long-acting thyroid stimulator.
    Brown J, Dorrington KJ, Ensor J, Smith BR, Munro DS.
    Proc R Soc Med; 1968 Dec 12; 61(12):1301-2. PubMed ID: 4177972
    [No Abstract] [Full Text] [Related]

  • 18. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
    Orgiazzi J, Pousset G, Durand H.
    Presse Med (1893); 1971 May 22; 79(25):1167-8. PubMed ID: 4933634
    [No Abstract] [Full Text] [Related]

  • 19. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R, Letonturier P, Sénécal P.
    Minerva Med; 1974 Mar 14; 65(19):995-8. PubMed ID: 4406464
    [No Abstract] [Full Text] [Related]

  • 20. [Etiology of Basedow's disease, with special reference to LATS].
    Nagata K.
    Naika Hokan; 1969 Jul 15; 16(7):297-317. PubMed ID: 4901097
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.